Cargill and Voyage Foods Launch Cocoa-Free Chocolate Alternative in North America

Cargill and Voyage Foods are bringing NextCoa, a cocoa-free confectionery alternative, to the US market, with Canada to follow. The product, which won a Gold Edison Award, is designed as a drop-in replacement for conventional chocolate in standard manufacturing processes.

Brand revitalization: Olay and Derma E target younger audiences with emotional connection

The beauty industry is continuously evolving, motivating legacy brands like Olay and US-based skin care brand Derma E to adopt new marketing strategies. The companies are refreshing their brands to maintain relevance, particularly among millennial and Gen Z consumers.

NYSCC Suppliers’ Day 2026: Grant and BCR partner for anti-aging ester

Grant Industries and BCR (Bio Component Research) will be showcasing their ester for skin longevity, Bakuchiol NAD+ BCR, and discussing AI-inspired beauty at NYSCC Suppliers’ Day 2026 in New York City, US (May 19–20).

L’Oréal previews olfactory art experience and expands in Saudi Arabia

Dataland, the world’s first omni-sensory Museum of AI Arts, co-founded by Refik Anadol and Efsun Erkılıç, in collaboration with L’Oréal Luxe, is set to open in Los Angeles, US.

Gene Therapy ETX101 Improves Seizures and Neurodevelopment in Dravet Syndrome in Phase I/II

Dravet syndrome has long represented one of the most challenging pediatric epilepsies encountered in neurology and genetic medicine. Caused primarily by loss‑of‑function variants in SCN1A, the disorder emerges in infancy with prolonged febrile seizures and evolves into a lifelong condition marked by treatment‑resistant epilepsy, developmental delay, and significant morbidity. As the gene and cell therapy community gathers for the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, the field’s attention is turning toward approaches capable not only of reducing seizures but also of altering the developmental trajectory that defines the disorder. This year’s Presidential Symposium features new data on ETX101, an investigational gene regulation therapy from Encoded Therapeutics, that appears to move the needle on both fronts.

CMN延长农村信贷环境要求的截止日期。

国家货币委员会(CMN)在本周二(12日)召开的特别会议上批准推迟并错开农村信贷环境合规性要求的实施时间表。这项措施旨在调整森林砍伐监测标准的实施,是南里奥格兰德州农业联合会(Farsul)和巴西农业和畜牧业联合会(CNA)牵头开展的制度性改革的直接成果。

Brightseed layers agentic AI onto Forager bioactives discovery platform with Hummingbird launch

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Brightseed.] Brightseed—a startup on a mission to i…

BTU Biotech Company Presents Sclerocid Research on White-Mold Biocontrol at EGU General Assembly 2026

Ukrainian biotechnology company BTU presented research on Sclerocid®, a multi-strain microbial biofungicide for the control of white mold (Sclerotinia sclerotiorum), at the EGU General Assembly 2026 — Europe’s largest geoscience and Earth-sciences conference — held in Vienna and online from 3–8 May 2026.

投资数千万欧元!巴斯夫BioHub发酵工厂落成,生物植保迈入工业规模化新阶段

世界农化网中文网报道: 巴斯夫农业解决方案部门近日在路德维希港基地成功启用其新发酵工厂BioHub,用于生产基于生物及生物技术的植保产品。该项投资额达数千万欧元,将强化巴斯夫在生物创新领域的产品组合。该工厂生产的产品包括生物杀菌剂和生物种子处理剂,为农民提供可纳入综合植保方案的创新型产品。

Millions for Preclinical Immunology: Boehringer Teams Up with Immunitas

With another immunology deal, Boehringer Ingelheim is further expanding its footprint in the fast-moving field of cell-selective autoimmune therapies. Global rights to a preclinical antibody programme from Immunitas Therapeutics could be worth up to €407.5m in total, underlining how competitive the race for next-generation inflammation therapies has become.